These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6125261)

  • 41. [Cardiotoxicity of anthracyclines].
    Laurent S; Colbert N; Izrael V; Motte G
    Ann Med Interne (Paris); 1984; 135(6):464-72. PubMed ID: 6391323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological and morphometrical assessment.
    Anjos Ferreira AL; Russell RM; Rocha N; Placido Ladeira MS; Favero Salvadori DM; Oliveira Nascimento MC; Matsui M; Carvalho FA; Tang G; Matsubara LS; Matsubara BB
    Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):16-24. PubMed ID: 17577311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
    Conklin KA
    Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes of hydroxyproline levels in myocardium after chronic administration of bleomycin.
    Anasiewicz A; Wójcik K; Abramowicz K; Lakowska H; Bentkowski M; Przywra S; Radzikowska E
    Folia Morphol (Warsz); 1996; 55(4):206-7. PubMed ID: 9243850
    [No Abstract]   [Full Text] [Related]  

  • 45. Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats.
    Bennink RJ; van den Hoff MJ; van Hemert FJ; de Bruin KM; Spijkerboer AL; Vanderheyden JL; Steinmetz N; van Eck-Smit BL
    J Nucl Med; 2004 May; 45(5):842-8. PubMed ID: 15136635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of anthracycline drugs on rat heart and liver microsomal reduced nicotinamide adenine dinucleotide phosphate-dependent lipid peroxidation.
    Mimnaugh EG; Trush MA; Ginsburg E; Gram TE
    Cancer Res; 1982 Sep; 42(9):3574-82. PubMed ID: 6809311
    [No Abstract]   [Full Text] [Related]  

  • 47. Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity.
    Minotti G; Mancuso C; Frustaci A; Mordente A; Santini SA; Calafiore AM; Liberi G; Gentiloni N
    J Clin Invest; 1996 Aug; 98(3):650-61. PubMed ID: 8698856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.
    Minotti G; Cavaliere AF; Mordente A; Rossi M; Schiavello R; Zamparelli R; Possati G
    J Clin Invest; 1995 Apr; 95(4):1595-605. PubMed ID: 7706466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The structure of SN-07 chromophore.
    Kimura K; Nakayama S; Miyata N; Takeshita Y; Kawanishi G
    J Antibiot (Tokyo); 1988 Mar; 41(3):411-4. PubMed ID: 3366698
    [No Abstract]   [Full Text] [Related]  

  • 50. Antitumor anthracyclines: recent developments.
    Arcamone F
    Med Res Rev; 1984; 4(2):153-88. PubMed ID: 6374338
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of uridine transport through sarcoma-180 cell membrane by anthracycline antibiotics.
    Choudhury SR; Deb JK; Choudhury K; Neogy RK
    Biochem Pharmacol; 1982 May; 31(9):1811-4. PubMed ID: 6954953
    [No Abstract]   [Full Text] [Related]  

  • 52. [Mechanism of the toxic effect of rubomycin on the organism].
    Abinder AA; Goldberg LE; Shepelevtseva NG; Vertogradova TP; Beskrovnova NN
    Antibiotiki; 1972 Feb; 17(2):147-52. PubMed ID: 5023459
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs: possible relationship to cardiotoxicity.
    Lehotay DC; Levey BA; Rogerson BJ; Levey GS
    Cancer Treat Rep; 1982 Feb; 66(2):311-6. PubMed ID: 6120040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of vivo doxorubicin (adriamycin) and aclacinomycin administration on guanylate cyclase activity in rat tissue.
    Lehotay DC; Levey BA; Rogerson BJ; Levey GS
    Proc Soc Exp Biol Med; 1981 Sep; 167(4):459-62. PubMed ID: 6116236
    [No Abstract]   [Full Text] [Related]  

  • 55. Modes of resistance to anthracyclines and other natural products.
    Kessel D; Romine M; Decker D
    Prog Clin Biol Res; 1986; 223():81-93. PubMed ID: 3543948
    [No Abstract]   [Full Text] [Related]  

  • 56. [Anthracycline cardiotoxicity: review].
    Ribera JM; Montserrat E; Rozman C
    Sangre (Barc); 1983; 28(1):54-68. PubMed ID: 6346540
    [No Abstract]   [Full Text] [Related]  

  • 57. Lack of correlation between effects of anthracyclines on in vitro cardiac guanyl cyclase and in vivo cardiotoxicity.
    Zbinden G
    Cancer Treat Rep; 1982 Aug; 66(8):1677-8. PubMed ID: 6125261
    [No Abstract]   [Full Text] [Related]  

  • 58. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
    Levey BA; Ruiz E; Rogerson B; Lehotay DC; Levey GS
    Cancer Treat Rep; 1980; 64(10-11):1127-8. PubMed ID: 6109566
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.